B-CELL MALIGNANCY

Clinical trials for B-CELL MALIGNANCY explained in plain language.

Never miss a new study

Get alerted when new B-CELL MALIGNANCY trials appear

Sign up with your email to follow new studies for B-CELL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 1 Not yet finished but already full! 1 Terminated 1

CRISPR cancer therapy shows promise in early trial

Disease control Terminated

This study tested a new treatment called CTX110 for people with B-cell blood cancers that came back or didn't respond to standard therapy. CTX110 uses CRISPR gene editing to create donor immune cells that can attack cancer. The study aimed to find safe doses and check if the trea…

Matched conditions: B-CELL MALIGNANCY

Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control

Last updated Jun 16, 2026 12:51 UTC

B-CELL MALIGNANCY

Get alerted when new B-CELL MALIGNANCY trials appear

CRISPR cancer therapy shows promise in early trial